Common Brands Actos
Drug Class
Controlled Substance Classification
Not a controlled medication
Generic Status
Lower-cost generic available
Prescription only
Shifali Patel, PharmD
Shifali Patel, PharmD
Read More
Medically reviewed by Shifali Patel, PharmD last update on 20/12/2023


Accolate, scientifically known as zafirlukast, is a medication classified as a leukotriene receptor antagonist. Approved by regulatory authorities, this drug has proven efficacy in managing specific health conditions, making it a valuable option in the realm of respiratory health.

Accolate was developed to address inflammatory responses associated with conditions such as asthma and allergic rhinitis. Approved by regulatory bodies after rigorous clinical trials, the drug has become a cornerstone in the treatment of these respiratory disorders.

At the core of Accolate’s effectiveness lies its ability to inhibit leukotrienes, which are potent inflammatory mediators. Leukotrienes play a crucial role in the inflammatory cascade, particularly in the respiratory system. By blocking the action of leukotrienes, Accolate helps mitigate inflammation, leading to improved respiratory function.

Accolate is typically available in oral tablet form. The recommended dosage may vary based on the specific condition being treated and individual patient factors. Healthcare providers prescribe Accolate with precise instructions to ensure optimal therapeutic outcomes.



Prescription only

Pregnancy & Lactation